+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurodiagnostics Market - Global Forecast 2026-2032- Product Image
Neurodiagnostics Market - Global Forecast 2026-2032- Product Image
New

Neurodiagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5014094
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neurodiagnostics market is in a phase of significant evolution, driven by emerging technologies, changing care models, and increasingly complex clinical needs. Senior decision-makers are called to recalibrate strategies and investment to stay ahead within this dynamically shifting diagnostic landscape.

Market Snapshot: Neurodiagnostics Market Growth and Outlook

The neurodiagnostics market expanded from USD 8.70 billion in 2025 to USD 9.50 billion in 2026 and is forecasted to reach USD 16.86 billion by 2032, reflecting an anticipated CAGR of 9.90%. This robust pace highlights a global upsurge in neurological disease impact and a parallel demand for advanced, multimodal diagnostic capabilities from healthcare providers and payers. As neurological conditions require faster, more precise diagnosis, the adoption of integrated solution sets is steadily increasing, informing new business models within both established and emerging territories.

Scope & Segmentation: Comprehensive Coverage of the Neurodiagnostics Market

This report provides an exhaustive analysis across the critical components and user groups shaping neurodiagnostics worldwide. Examination of these domains supplies actionable detail to guide strategic decisions:

  • Technology Types: Invasive neurodiagnostic modalities include depth electrode monitoring and electrocorticography, supporting direct neural assessment. Noninvasive approaches—such as EEG, MEG, CT, and MRI—enable safer, more scalable diagnostics. Hybrid solutions that combine electrophysiology with imaging are increasingly adopted to enhance precision and streamline clinical pathways.
  • Clinical Applications: Technologies are deployed for the diagnosis and monitoring of major neurological conditions, including Alzheimer’s disease, various forms of stroke, epilepsy, brain tumors, trauma, and multiple sclerosis. Special attention is given to evolving protocols in differential diagnosis, pre-surgical planning, and chronic disease surveillance, underscoring the growing complexity of patient journeys and care delivery.
  • End-User Segments: Neurodiagnostic solutions serve hospitals and specialty clinics, ambulatory neurology clinics, outpatient rehabilitation centers, independent and hospital-affiliated diagnostic centers, and academic research institutes. This diversity of settings accelerates innovation in device design and workflow integration, supporting a range of clinical objectives and patient populations.
  • Regional Analysis: The report covers market dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Both mature and emerging regions are profiled with respect to go-to-market strategies, care pathway integration, and regulatory diversity, offering a rounded perspective for companies scaling across borders.

Key Takeaways: Strategic Implications for Senior Decision-Makers

  • Integration of electrophysiology and imaging systems is changing diagnostic approaches, enabling clinicians to localize brain conditions with greater accuracy and support individualized treatment planning for complex cases.
  • The movement toward ambulatory and home-based neurodiagnostics, supported by portable technologies and remote interfaces, is reshaping device development and reimbursement priorities. This shift is meeting expanding needs for continuous patient monitoring and cost-effective care.
  • Regulatory expectations now emphasize clinical validation, device safety, and data protection at each phase of market entry and post-market deployment, resulting in increased scrutiny and the need for enhanced project management and resource allocation.
  • Strategic partnerships involving manufacturers, health systems, and software vendors are accelerating product innovation and clinical evidence generation, allowing more rapid adoption of integrated, value-driven solutions.
  • Effective commercialization requires clear alignment between technical features and quantitative clinical benefits, backed by robust supporting evidence and implementation strategies tailored to real-world operational constraints.

Tariff Impact: Navigating Supply Chain and Sourcing Complexities

  • Recent tariff changes have significantly raised import and compliance expenses for core neurodiagnostic components, compelling manufacturers to reevaluate sourcing origins and product design methodologies.
  • In response, producers are diversifying suppliers, considering nearshoring, and developing modular devices that support localized part substitution, all to maintain supply security and cost controls.
  • Distributors and healthcare systems are managing tighter inventories, introducing staged equipment roll-outs to minimize uncertainty and sustain uninterrupted clinical service.
  • The increasing importance of service-enabled solutions—such as remote device monitoring, cloud-hosted analytics, and bundled support—reflects sector efforts to counteract hardware cost escalations and generate ongoing value streams.

Methodology & Data Sources

This market analysis draws on a mixed-methods approach. Findings are informed by primary interviews with clinicians and procurement stakeholders, combined with rigorous review of peer-reviewed clinical literature, regulatory texts, and technical documentation. Advisory feedback supports validity and practical relevance.

Why This Report Matters

  • Empowers senior executives to optimize investments and align strategic partnerships by grounding decisions in actionable, clinically relevant market insights.
  • Enables organizations to develop resilient, scalable strategies in response to ongoing advances in neurodiagnostic technology, regulatory shifts, and regional market challenges.
  • Provides targeted segmentation, comprehensive technology evaluation, and practical guidance for aligning product development with the operational needs of various clinical end users.

Conclusion

Integrated, validated, and agile neurodiagnostic solutions are reshaping the sector. Equipped with current intelligence, stakeholders can negotiate growing complexity, expand clinical adoption, and sustain commercial progress in a demanding market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Neurodiagnostics Market, by Technology
8.1. Invasive
8.1.1. Depth Electrode Monitoring
8.1.2. Electrocorticography
8.2. Noninvasive
8.2.1. Electrophysiology
8.2.2. Imaging Modalities
9. Neurodiagnostics Market, by Application
9.1. Alzheimer's Disease
9.1.1. Lewy Body Dementia
9.1.2. Vascular Dementia
9.2. Brain Tumor
9.3. Epilepsy
9.3.1. Focal Epilepsy
9.3.2. Generalized Epilepsy
9.4. Multiple Sclerosis
9.5. Stroke
9.5.1. Hemorrhagic Stroke
9.5.2. Ischemic Stroke
9.6. Trauma
10. Neurodiagnostics Market, by End User
10.1. Ambulatory Clinics
10.1.1. Neurology Clinics
10.1.2. Outpatient Rehabilitation Centers
10.2. Diagnostic Centers
10.2.1. Hospital Owned Diagnostic Centers
10.2.2. Independent Diagnostic Centers
10.3. Home Care
10.4. Hospitals
10.4.1. General Hospitals
10.4.2. Specialty Clinics
10.5. Research Institutes
11. Neurodiagnostics Market, by Region
11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific
12. Neurodiagnostics Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Neurodiagnostics Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. United States Neurodiagnostics Market
15. China Neurodiagnostics Market
16. Competitive Landscape
16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. Advanced Brain Monitoring, Inc.
16.6. BioSerenity
16.7. Brainscope Co. Inc.
16.8. Cadwell Laboratories, Inc.
16.9. Canon Medical Systems Corporation
16.10. Compumedics Limited
16.11. Electrical Geodesics, Inc.
16.12. F. Hoffmann-La Roche Ltd
16.13. FUJIFILM Holdings Corporation
16.14. GE HealthCare Corporation
16.15. Koninklijke Philips N.V.
16.16. Lifelines Neuro Company, LLC
16.17. Medtronic plc
16.18. Natus Medical Incorporated
16.19. NeuroMetrix, Inc.
16.20. Neurosigma, Inc.
16.21. NeuroSky, Inc.
16.22. Neurosoft
16.23. Nicolet Neurodiagnostic Products, Inc.
16.24. Nihon Kohden Corporation
16.25. Persyst Development Corporation
16.26. Rhythmlink International, LLC
16.27. Siemens Healthineers AG
16.28. Thermo Fisher Scientific, Inc.
List of Figures
FIGURE 1. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEPTH ELECTRODE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEPTH ELECTRODE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEPTH ELECTRODE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROPHYSIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROPHYSIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROPHYSIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY IMAGING MODALITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY IMAGING MODALITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY IMAGING MODALITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY LEWY BODY DEMENTIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY LEWY BODY DEMENTIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY LEWY BODY DEMENTIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY VASCULAR DEMENTIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY VASCULAR DEMENTIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY VASCULAR DEMENTIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BRAIN TUMOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BRAIN TUMOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BRAIN TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY FOCAL EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY FOCAL EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY FOCAL EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERALIZED EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERALIZED EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERALIZED EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEMORRHAGIC STROKE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEMORRHAGIC STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL OWNED DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL OWNED DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL OWNED DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 155. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 157. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 173. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 175. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 176. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 177. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 179. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 180. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 181. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 183. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 184. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 200. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 201. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 202. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 204. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 206. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 208. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 209. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 210. GCC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GCC NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. GCC NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 213. GCC NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 214. GCC NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. GCC NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 216. GCC NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 217. GCC NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 218. GCC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. GCC NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 220. GCC NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 221. GCC NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 234. BRICS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. BRICS NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 237. BRICS NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 238. BRICS NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. BRICS NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 240. BRICS NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 241. BRICS NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 242. BRICS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. BRICS NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 244. BRICS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 245. BRICS NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 246. G7 NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. G7 NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. G7 NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 249. G7 NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 250. G7 NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. G7 NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 252. G7 NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 253. G7 NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 254. G7 NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. G7 NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 256. G7 NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 257. G7 NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 258. NATO NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. NATO NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 260. NATO NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 261. NATO NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 262. NATO NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. NATO NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 264. NATO NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 265. NATO NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 266. NATO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. NATO NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 268. NATO NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 269. NATO NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 283. CHINA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. CHINA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 285. CHINA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 286. CHINA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
TABLE 287. CHINA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 288. CHINA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
TABLE 289. CHINA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 290. CHINA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 291. CHINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. CHINA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
TABLE 293. CHINA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 294. CHINA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Neurodiagnostics market report include:
  • Advanced Brain Monitoring, Inc.
  • BioSerenity
  • Brainscope Co. Inc.
  • Cadwell Laboratories, Inc.
  • Canon Medical Systems Corporation
  • Compumedics Limited
  • Electrical Geodesics, Inc.
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • GE HealthCare Corporation
  • Koninklijke Philips N.V.
  • Lifelines Neuro Company, LLC
  • Medtronic plc
  • Natus Medical Incorporated
  • NeuroMetrix, Inc.
  • Neurosigma, Inc.
  • NeuroSky, Inc.
  • Neurosoft
  • Nicolet Neurodiagnostic Products, Inc.
  • Nihon Kohden Corporation
  • Persyst Development Corporation
  • Rhythmlink International, LLC
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.5 Billion
Forecasted Market Value ( USD ) by 2032 $ 16.86 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Neurodiagnostics - Global Strategic Business Report - Product Image

Neurodiagnostics - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Neurodiagnostics Market Report 2025 - Product Image

Neurodiagnostics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
2025 Global Forecast for Neurodiagnostics Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Neurodiagnostics Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Neurodiagnostic And Monitoring Devices Market in the US 2025-2029 - Product Image

Neurodiagnostic And Monitoring Devices Market in the US 2025-2029

  • Report
  • 202 Pages
  • United States
From
IVD in Cardiology and Neurology - Global Strategic Business Report - Product Image

IVD in Cardiology and Neurology - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From

About the Neurodiagnostics Market

The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases. The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market. Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.